Bioorganic & medicinal chemistry letters

Development of l-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding …

YL Song, PP Roller, YQ Long

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 12 p. 3205 - 3208

Full Text: HTML

Citation Number: 15

Abstract

... Bioorganic & Medicinal Chemistry Letters. ... b Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, 376 Boyles Street, Frederick, MD ... containing Grb2-SH2 domain antagonists, and potentially may find value in the chemical therapeutics of ...

Related Articles:

Lipid peroxyl radicals mediate tyrosine dimerization and nitration in membranes

[Bartesaghi, Silvina; Wenzel, Jorge; Trujillo, Madia; Lopez, Marcos; Joseph, Joy; Kalyanaraman, Balaraman; Radi, Rafael Chemical Research in Toxicology, 2010 , vol. 23, # 4 p. 821 - 835]

Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives

[Journal of Medicinal Chemistry, , vol. 49, # 5 p. 1585 - 1596]

Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives

[Journal of Medicinal Chemistry, , vol. 49, # 5 p. 1585 - 1596]

A novel procedure for generating both nitric oxide and superoxide in situ from chemical sources at any chosen mole ratio. First application: tyrosine oxidation and a …

[Chemical Research in Toxicology, , vol. 13, # 12 p. 1287 - 1293]

More Articles...